The U.S. Multi-Cancer Early Detection Market is projected to grow from USD 0.24 Billion in 2025 to USD 1.18 Billion by 2035 at a 16.84% CAGR, while Europe is expected to increase from USD 0.48 Billion to USD 2.08 Billion, supported by NHS-GRAIL initiatives, favorable reimbursement policies, and expanding blood-based cancer screening programs.
The U.S. Multi-Cancer Early Detection Market is projected to grow from USD 0.24 Billion in 2025 to USD 1.18 Billion by 2035 at a 16.84% CAGR, while Europe is expected to increase from USD 0.48 Billion to USD 2.08 Billion, supported by NHS-GRAIL initiatives, favorable reimbursement policies, and expanding blood-based cancer screening programs.